Authorisation requise
RHD deletion in a patient with chronic myeloid leukemia
, , , , , , et
25 mars 2020
À propos de cet article
Catégorie d'article: Case Report
Publié en ligne: 25 mars 2020
Pages: 160 - 164
DOI: https://doi.org/10.21307/immunohematology-2019-291
Mots clés
© 2008 A. Murdock, et al., published by Sciendo
Murdock, A.
Good Samaritan Hospital Medical CenterWest Islip, NY
Assip, D.
Good Samaritan Hospital Medical CenterWest Islip, NY
Hue-Roye, K.
Laboratory of Immunochemistry, New York Blood CenterNew York, NY
Lomas-Francis, C.
Laboratory of Immunohematology, New York Blood CenterLong Island City, NY
Hu, Z.
Laboratory of Immunohematology, New York Blood CenterLong Island City, NY
Vege, S.
Molecular Blood Group and Platelet Testing Laboratory, American Red CrossPhiladelphia, PA
Westhoff, C.M.
Molecular Blood Group and Platelet Testing Laboratory, American Red CrossPhiladelphia, PA
Reid, M.E.
New York Blood CenterNew York, NY